PDF(1089 KB)
PDF(1089 KB)
PDF(1089 KB)
儿童急性淋巴细胞白血病化疗后合并肺部感染的临床特征
Clinical features of children with acute lymphoblastic leukemia complicated by pulmonary infection after chemotherapy
目的 分析化疗后合并肺部感染的急性淋巴细胞白血病（ALL）患儿的临床特征，为ALL合并肺部感染的早期诊断提供依据。方法 对115例次化疗后合并肺部感染且行肺部CT的ALL患儿（108例）进行回顾性分析，收集患者一般临床资料及肺部螺旋CT结果，探究肺部感染发生的危险因素，以及病原体与肺部CT的影像学特点。结果 儿童ALL化疗后的肺部感染77.4%发生于诱导缓解阶段，多发生于化疗后的31~60 d，以粒缺患儿所占比例（67.0%）最高。病原学拟诊或确诊的41例肺部感染患儿以细菌感染（36%）与真菌感染（41%）的发生率较高。细菌或真菌感染所致肺部病变CT表现的差异无统计学意义（P > 0.05）。结论 ALL患儿在化疗诱导缓解阶段，尤其是粒细胞缺乏时肺部感染发生率高。细菌和/或真菌是主要病原体，难以根据肺部影像学改变明确肺部感染的性质。
Objective To examine the clinical features of children with acute lymphoblastic leukemia (ALL) complicated by pulmonary infection after chemotherapy. Methods The clinical data of 108 ALL children (115 case-times) with post-chemotherapy pulmonary infection were retrospectively reviewed. The risk factors for pulmonary infection and the relationship between pathogens and chest CT findings were evaluated. Results The highest incidence (77.4%) of pulmonary infection occurred during remission induction, peaking at 31-60 days after chemotherapy. Patients with neutropenia had the highest incidence rate of pulmonary infection (67.0%). Bacteria (36%) and fungi (41%) were the two most common pathogens in the 41 patients who were etiologically suspected of or diagnosed with pulmonary infection. There was no significant difference in chest CT findings between patients with bacterial and fungal infections. Conclusions The children with ALL are most susceptible to pulmonary infection during remission induction, especially when they are neutropenic. Bacteria and fungi are the main pathogens of pulmonary infections in these patients. However, the changes in chest CT images are poor indicators of the nature of pulmonary infection.
[1] Cheng S, Pole JD, Sung L. Early deaths in pediatric acute leukemia:a population-based study[J]. Leuk Lymphoma, 2014, 55(7):1518-1522.
[2] Depasse J, Caniza M A, Quessar A, et al. Infections in hospitalized children and young adults with acute leukemia in Morocco[J]. Pediatr Blood Cancer, 2013, 60(6):916-922.
[3] Taj M, Farzana T, Shah T, et al. Clinical and microbiological profile of pathogens in febrile neutropenia in hematological malignancies:A single center prospective analysis[J]. J Oncol, 2015, 2015:596504.
[4] Noorifard M, Sekhavati E, Jalaei Khoo H, et al. Epidemiology and clinical manifestation of fungal infection related to Mucormycosis in hematologic malignancies[J]. J Med Life, 2015, 8(Spec Iss 2):32-37.
[5] Gulati M, Kaur R, Jha V, et al. High-resolution CT in renal transplant patients with suspected pulmonary infections[J]. Acta Radiol, 2000, 41(3):237-241.
[6] 徐基昕, 孔令军, 张淑红, 等. 甲氨蝶呤治疗儿童急性淋巴细胞白血病致白质脑病二例[J]. 白血病·淋巴瘤, 2016, 25(10):623-625.
[7] 黄晓军. 血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第四次修订版)[J]. 中华内科杂志, 2013, 52(8):710-711.
[8] Driscoll A J, Deloria Knoll M, Hammitt LL, et al. The effect of antibiotic exposure and specimen volume on the detection of bacterial pathogens in children with pneumonia[J]. Clin Infect Dis, 2017, 64(Suppl 3):S368-S377.
[9] Chen K, Jia R, Li L, et al. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patterns associated with age and season[J]. BMC Public Health, 2015, 15:113.
[10] Inaba H, Pei D, Wolf J, et al. Infection-related complications during treatment for childhood acute lymphoblastic leukemia[J]. Ann Oncol, 2017, 28(2):386-392.
[11] 陈再生, 郑灵, 陈以乔, 等. 儿童急性淋巴细胞白血病诱导缓解期感染的病原菌及耐药情况分析[J]. 中国当代儿科杂志, 2017, 19(2):176-181.
[12] Pagano L, Caira M. Risks for infection in patients with myelodysplasia and acute leukemia[J]. Curr Opin Infect Dis, 2012, 25(6):612-618.
[13] Biswal S, Godnaik C. Incidence and management of infections in patients with acute leukemia following chemotherapy in general wards[J]. Ecancermedicalscience, 2013, 7:310.
[14] Hakim H, Flynn PM, Knapp KM, et al. Etiology and clinical course of febrile neutropenia in children with cancer[J]. J Pediatr Hematol Oncol, 2009, 31(9):623-629.
[15] Ali N, Adil SN, Shaikh MU. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients:data from a developing country[J]. Transpl Infect Dis, 2014, 16(1):98-105.
[16] Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group[J]. Medicine (Baltimore), 2000, 79(4):250-260.
国家自然科学基金（81270632）。
